UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

The New England journal of medicine, 2019-03, Vol.380 (11), p.1022-1032

2019

Volltextzugriff (PDF)

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

The Lancet regional health. Europe, 2023-06, Vol.29, p.100624-100624, Article 100624

2023

Volltextzugriff (PDF)

Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials

Expert opinion on pharmacotherapy, 2005-06, Vol.6 (6), p.915-927

2005

Volltextzugriff (PDF)

The year in cardiology: cardiovascular prevention

European heart journal, 2020-03, Vol.41 (11), p.1157-1163

2020

Volltextzugriff (PDF)

Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial

Journal of Alzheimer's disease, 2021-01, Vol.83 (4), p.1703-1715

2021

Volltextzugriff (PDF)

PCV77 - Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

Value in health, 2016-11, Vol.19 (7), p.A650-A650

2016

Volltextzugriff (PDF)

Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

Value in health, 2016-11, Vol.19 (7), p.A650-A650

2016

Volltextzugriff (PDF)

Evolocumab and clinical outcomes in patients with cardiovascular disease

The Journal of the Royal College of Physicians of Edinburgh, 2017-06, Vol.47 (2), p.153-155

2017

Volltextzugriff (PDF)

Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review

Value in health, 2017-10, Vol.20 (9), p.A606

2017

Volltextzugriff (PDF)

PCV32 - Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review

Value in health, 2017-10, Vol.20 (9), p.A606-A606

2017

Volltextzugriff (PDF)

CV1 - The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses

Value in health, 2015-11, Vol.18 (7), p.A340-A340

2015

Volltextzugriff (PDF)

Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom

Value in health, 2017-10, Vol.20 (9), p.A605-A606

2017

Volltextzugriff (PDF)

PCV31 - Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom

Value in health, 2017-10, Vol.20 (9), p.A605-A606

2017

Volltextzugriff (PDF)

The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses

Value in health, 2015-11, Vol.18 (7), p.A340-A340

2015

Volltextzugriff (PDF)

PCV183 - Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

Value in health, 2015-11, Vol.18 (7), p.A406-A406

2015

Volltextzugriff (PDF)

Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

Value in health, 2015-11, Vol.18 (7), p.A406-A406

2015

Volltextzugriff (PDF)

Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data

Value in health, 2015-11, Vol.18 (7), p.A387-A387

2015

Volltextzugriff (PDF)

Lipid management: maximising reduction of cardiac risk

Clinical medicine (London, England), 2013-12, Vol.13 (6), p.618-620

2013

Volltextzugriff (PDF)

PCV78 - Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data

Value in health, 2015-11, Vol.18 (7), p.A387-A387

2015

Volltextzugriff (PDF)

Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

European cardiology, 2023, Vol.18, p.e36-e36

2023

Volltextzugriff (PDF)

An FCC phase in a metastable [Beta]-titanium alloy

Philosophical magazine letters, 2014-05, Vol.94 (5), p.311

2014

Volltextzugriff (PDF)

Lipid management: maximising reduction of cardiac risk

Clinical medicine (London, England), 2013-12, Vol.13 (6), p.618-620

2013

Volltextzugriff (PDF)

SHG Bank Linkage: Lending a Helping Hand?

Vision (New Delhi, India), 2014-09, Vol.18 (3), p.245-250

2014

Volltextzugriff (PDF)

Determination of Drospirenone in Human Plasma by LC-Tandem-MS

Chromatographia, 2008-11, Vol.68 (9-10), p.713-720

2008

Volltextzugriff (PDF)

Physiological Level of LDL Cholesterol: The Master Key A Nobel Dream Comes True

Cardiovascular pharmacology: open access, 2017, Vol.6 (5)

2017

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Aktive Filter

ThemaCardiovascular System & Cardiology

ThemaTechnology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(158)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials

The year in cardiology: cardiovascular prevention

Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial

PCV77 - Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

Evolocumab and clinical outcomes in patients with cardiovascular disease

Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review

PCV32 - Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review

CV1 - The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses

Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom

PCV31 - Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom

The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses

PCV183 - Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data

Lipid management: maximising reduction of cardiac risk

PCV78 - Costs Of Cardiovascular (Cv) Events In The United Kingdom (Uk) Using Real-World Data

Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

An FCC phase in a metastable [Beta]-titanium alloy

Lipid management: maximising reduction of cardiac risk

SHG Bank Linkage: Lending a Helping Hand?

Determination of Drospirenone in Human Plasma by LC-Tandem-MS

Physiological Level of LDL Cholesterol: The Master Key A Nobel Dream Comes True

Aktive Filter

Suchergebnisse filtern